HomeComparePLRTF vs PFE

PLRTF vs PFE: Dividend Comparison 2026

PLRTF yields 5442.18% · PFE yields 6.20%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLRTF wins by $141840815997033.34M in total portfolio value
10 years
PLRTF
PLRTF
● Live price
5442.18%
Share price
$0.04
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$141840815997033.41M
Annual income
$136,892,639,061,083,600,000.00
Full PLRTF calculator →
PFE
Pfizer Inc.
● Live price
6.20%
Share price
$27.76
Annual div
$1.72
5Y div CAGR
13.2%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$51.1K
Annual income
$27,210.54
Full PFE calculator →

Portfolio growth — PLRTF vs PFE

📍 PLRTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodPLRTFPFE
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, PLRTF + PFE cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
PLRTF pays
PFE pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

PLRTF
Annual income on $10K today (after 15% tax)
$462,585.03/yr
After 10yr DRIP, annual income (after tax)
$116,358,743,201,921,060,000.00/yr
PFE
Annual income on $10K today (after 15% tax)
$526.66/yr
After 10yr DRIP, annual income (after tax)
$23,128.96/yr
At 15% tax rate, PLRTF beats the other by $116,358,743,201,921,040,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of PLRTF + PFE for your $10,000?

PLRTF: 50%PFE: 50%
100% PFE50/50100% PLRTF
Portfolio after 10yr
$70920407998516.72M
Annual income
$68,446,319,530,541,820,000.00/yr
Blended yield
96.51%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PFE right now

PLRTF
No analyst data
Altman Z
-39.1
Piotroski
4/9
PFE
Analyst Ratings
16
Buy
22
Hold
1
Sell
Consensus: Hold
Price Target
$27.50
-0.9% upside vs current
Range: $24.00 — $35.00
Altman Z
2.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

PLRTF buys
0
PFE buys
0
No recent congressional trades found for PLRTF or PFE in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricPLRTFPFE
Forward yield5442.18%6.20%
Annual dividend / share$2.00$1.72
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%13.2%
Portfolio after 10y$141840815997033.41M$51.1K
Annual income after 10y$136,892,639,061,083,600,000.00$27,210.54
Total dividends collected$141506926769066.97M$60.1K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: PLRTF vs PFE ($10,000, DRIP)

YearPLRTF PortfolioPLRTF Income/yrPFE PortfolioPFE Income/yrGap
1← crossover$554,918$544,217.69$9,161$701.38+$545.8KPLRTF
2$28,817,689$28,223,927.12$8,610$859.79+$28.81MPLRTF
3$1,400,657,277$1,369,822,349.43$8,366$1,081.25+$1400.65MPLRTF
4$63,722,026,346$62,223,323,060.08$8,483$1,405.66+$63722.02MPLRTF
5$2,713,800,462,147$2,645,617,893,956.67$9,084$1,907.24+$2713800.45MPLRTF
6$108,204,567,767,273$105,300,801,272,775.55$10,418$2,732.78+$108204567.76MPLRTF
7$4,039,657,652,852,433$3,923,878,765,341,450.00$13,007$4,193.56+$4039657652.84MPLRTF
8$141,231,046,511,189,630$136,908,612,822,637,520.00$18,010$7,005.87+$141231046511.17MPLRTF
9$4,624,464,426,121,299,000$4,473,347,206,354,326,000.00$28,216$12,979.89+$4624464426121.27MPLRTF
10$141,840,815,997,033,400,000$136,892,639,061,083,600,000.00$51,081$27,210.54+$141840815997033.34MPLRTF

PLRTF vs PFE: Complete Analysis 2026

PLRTFStock

Plymouth Rock Technologies Inc. focuses on developing security screening and threat detection technology solutions using radar imaging and signal processing technology. Its technologies include Wireless Threat Indication, a wall or portal mounted sensor system that will detect concealed threat items over an extended coverage area; Shoe Scanner, a compact microwave radar system for scanning shoes; Millimeter Remote Imaging from Airborne Drone; PRT-X1, an unmanned aerial system (UAS) drone; XV, a fixed-wing UAS platform with the added capability of vertical take-off and landing; X1, a purpose built coaxial multirotor UAS; and Cognitive Object Detection Apparatus, a compact modular radar for aircraft and weapon detection applications. The company was incorporated in 2011 and is headquartered in Vancouver, Canada.

Full PLRTF Calculator →

PFEHealthcare

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Full PFE Calculator →
📬

Get this PLRTF vs PFE comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

PLRTF vs SCHDPLRTF vs JEPIPLRTF vs OPLRTF vs KOPLRTF vs MAINPLRTF vs JNJPLRTF vs MRKPLRTF vs ABBV

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.